Effects of BPA on Insulin and Glucose Responses
Completed · Not applicable · Has a placebo group
Conditions studied: Environmental Exposure
In brief
The National Institutes of Health has encouraged research examining effects of BPA, yet evidence in humans evaluating the effects of BPA on insulin and glucose concentrations remains exclusively associative in nature. Thus, the primary purpose of this study is to determine whether an acute oral ingestion of BPA impacts insulin and glucose concentrations, and other endocrine factors (Pro-insulin, C-Peptide, Estrogen, triglycerides). Findings from this pilot study will inform public health recommendations for food packaging and provide much needed experimental evidence as to whether BPA poses any public health risk.
Key facts
- Study ID
- NCT03444922
- Run by
- California Polytechnic State University-San Luis Obispo
- People needed
- 11
- Starts
- 2016-09-01
- Expected to finish
- 2019-02-14
- Last updated by the study team
- 2019-02-18
Who can join
Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- BMI = 18.5-35
- Age 18-50 years
- Non-smoking
- English speaking
You may not qualify if…
- History of infertility
- Type 2 or Type 1 diabetes
- Cardiovascular disease, or any other metabolic disease/complication
- Hypertension (systolic blood pressure ≥140, diastolic blood pressure ≥90) assessed by sphygmomanometer
- History of major psychiatric illness, drug abuse, or unsafe dieting practices
- History of bariatric surgery
- Pregnant women or women expecting or trying to become pregnant
- Participating in other studies
Where it is running
- California Polytechnic State University — San Luis Obispo, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.